Company Name: Replimune Group, Inc.
Replimune Group, Inc. is a clinical stage biotechnology company. The company is engaged in the development of oncolytic immunotherapies for cancer.
Ticker Symbol: REPL (NASDAQ)
Company Website: https://www.replimune.com
Social Media:
Headquarters: Woburn, MA